Bringing over 25 years of hands-on experience in life sciences and partnership management, Dr Davenport’s appointment ...

FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...

For decades, discovery has relied on "brute force" mass-screening – testing thousands of random compounds hoping one will ...

In today’s ACT Brief, we examine why life sciences companies are maintaining DEI commitments amid political pressure, what’s ...

Top of the list is that AIs must be human-centric by design and align with ethical values. They must be developed using a ...

Yoo Chang-ho, head of strategy at SK Biopharmaceuticals, left, and Bae Min-seok, CEO of PhnyX Lab, pose for a commemorative photo marking the signing of a memorandum of understanding on AI-based drug ...

Advances in inflammasome biology are helping researchers address key selectivity and safety challenges in drug development.

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...